All Sites Sorted » Health Beauty and Fitness » Medicine




Latest News

Forbes Earnings Preview: Regeneron Pharmaceuticals
Regeneron Pharmaceuticals reports its third-quarter earnings on Tuesday, November 4, 2014, and the consensus earnings per share estimate is $2.10 per share.The consensus estimate is down from three months ago when it was $2.62, but is unchanged over the past month. Analysts are expecting earnings of $7.95 per share for Fri, 31 Oct 2014 06:29:28 -0700

Aegerion Pharmaceuticals Announces Third-Quarter 2014 Financial Results
Company records $43.7 million in net product sales of JUXTAPID(R) Thu, 30 Oct 2014 13:05:00 -0700

Paratek Pharmaceuticals Completes Merger With Transcept Pharmaceuticals
BOSTON -- Paratek Pharmaceuticals, Inc. and Transcept Pharmaceuticals, Inc. (through October 30) today announced the two companies have completed their merger effective as of October 30, 2014. Thu, 30 Oct 2014 10:31:20 -0700

Arena Pharmaceuticals Loss Expected to Widen
Arena Pharmaceuticals is expected to book a wider loss than a year ago when it reports third-quarter earnings on Monday, November 3, 2014. Analysts are expecting a loss of 13 cents per share, down from a loss of eight cents per share a year ago.The consensus estimate hasn't changed over Thu, 30 Oct 2014 07:14:15 -0700

Tribute Pharmaceuticals Receives Uracyst(R) Patent in Europe
Tribute Pharmaceuticals Canada Inc. , today announced that it has received a patent approval from the European Patent Office for intellectual property central to one of the Company's lead products, Uracyst ... Thu, 30 Oct 2014 05:40:44 -0700

Ciclofilin Pharmaceuticals Appoints Michael Kamdar to its Board of Directors
SAN DIEGO -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today the appointment of Michael Kamdar ... Thu, 30 Oct 2014 04:00:00 -0700

Spectrum Pharmaceuticals Announces Third Quarter 2014 Financial Results Teleconference and Webcast
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, Thu, 30 Oct 2014 04:00:00 -0700

Synergy Pharmaceuticals Inc. Announces Full Exercise of Over-Allotment Option
Synergy Pharmaceuticals Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, today announced the full exercise of the over-allotment option granted to the initial purchasers to purchase an additional $25 million aggregate principal amount of 7.50% Convertible Senior Notes due 2019 in connection with its previously announced $175 million Convertible Senior Note ... Thu, 30 Oct 2014 03:00:00 -0700

ANI Pharmaceuticals (ANIP) Shows Strength: Stock Up 6.8%
ANI Pharmaceuticals was a big mover last session, as its shares rose almost 7% on the day. Thu, 30 Oct 2014 00:19:31 -0700

Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss
Ligand Pharmaceuticals Incorporated (LGND) reported higher third-quarter earnings of 19 cents per share but fell short of the Zacks Consensus Estimate by 2 cents. Wed, 29 Oct 2014 10:00:02 -0700

Website Directory Sort by: Hits | Alphabetical


Top 5 Web Hosts

Top 5 Favorite Web Hosts

   1. HostGator
   2. LunarPages
   3. Yahoo! Web Hosting
   4. HostMonster
   5. BlueHost